Hemorheology in insulin resistance

Microcirculation and Insulin Resistance

Volumn , Issue , 2009, Pages 99-106

  Brun, Jean Frédéric ^a   Varlet Marie, Emmanuelle ^a,b   Aloulou, Ikram ^a   Sardinoux, Mathieu ^a   De Mauverger, Eric Raynaud ^a   Mercier, Jacques ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860446901     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805057410901010099     Document Type: Chapter

References (45)

1. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J. 2007; 28(3): 354-62.
2. Lowe GD. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb. 2003; 33(5-6): 455-7.
3. Brun JF. Hormones, metabolism and body composition as major determinants of blood rheology: potential pathophysiological meaning. Clin Hemorheol Microcirc. 2002; 26(2):63-79.
4. Quemada D. Rheology of concentrated disperse systems. II. A model of non newtonian shear viscosity in steady flows. Rheol Acta 1978; 17: 632-642.
5. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003; 29(5): 435-50.
6. Baskurt OK. In vivo correlates of altered blood rheology. Biorheology. 2008;45(6):629-38.
7. Gaudard A, Varlet-Marie E, Bressolle F, Mercier J, Brun JF. Hemorheological correlates of fitness and unfitness in athletes: moving beyond the apparent "paradox of hematocrit"? Clin Hemorheol Microcirc. 2003;28(3):161-73.
8. Brun JF Brun, C Dupuy-Fons, JF Monnier, JP Micallef, D Bouix, C Peyreigne and A Orsetti. Blood viscosity is negatively correlated to insulin sensitivity. Biorheology 32 (1995), 387-388.
9. Brun JF, Monnier JF, Kabbaj H, Orsetti A. La viscosité sanguine est corrélée à l'insulino-résistance. J Mal Vasc (Paris) 21 (1996), 171-174.
10. Moan, G. Nordby, I. Os, K.I. Birkeland and S.E. Kjeldsen, Relationship between hemorrheologic factors and insulin sensitivity in healthy young men, Metabolism 1994; 43: 423-427.
11. Fossum E, Høieggen A, Moan A, Nordby G, Velund TL, Kjeldsen SE. Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors. Blood Press. 1997; 6(3): 161-5.
12. Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens. 1998; 16(2):203-10.
13. Perez-Martin A, Dumortier M, Pierrisnard E, Raynaud E, Mercier J, Brun JF. Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance? Clin Hemorheol Microcirc. 2001;25(3-4): 91-103.
14. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004; 33(2):283-303.
15. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37(12): 1595-607.
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
17. Alberti, KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition, Lancet 366 (9491) (2005), pp. 1059-1062.
18. Reaven G. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease. Clin Chem. 2008; 54(5): 785-7.
19. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res. 2007; 4(1): 13-9.
20. Brun JF, Aloulou I, Varlet-Marie E. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Microcirc. 2004;30(3-4):203-9.
21. Aloulou I, Varlet-Marie E, Mercier J, Brun JF. Hemorheological disturbances correlate with the lipid profile but not with the NCEP-ATPIII score of the metabolic syndrome. Clin Hemorheol Microcirc. 2006;35(1-2):207-12.
22. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993; 42(11):1663-72.
23. Bergman RN. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med. 2002; 69(5):280-90.
24. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6): 1487-95.
25. Brun JF, Raynaud E, Mercier J. Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose. Diabetes Care. 2000; 23(7):1037-8.
26. Ferrannini E, Balkau B. Insulin: in search of a syndrome. Diabet Med. 2002;19(9):724-9.
27. Bergman RN and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11: 351-356, 2000.
28. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab. 2005; 288(2):E454-61.
29. Aloulou I, Varlet-Marie E, Mercier J, Brun JF. The hemorheological aspects of the metabolic syndrome are a combination of separate effects of insulin resistance, hyperinsulinemia and adiposity. Clin Hemorheol Microcirc. 2006; 35(1-2):113-9.
30. Worth H. Comparison of hydrofluoroalkane-beclomethasone dipropionate autohaler with budesonide Turbuhaler in asthma con-trol. Respiration 2001; 68: 517-26.
31. Raynaud E, Brun JF, Perez-Martin A, Orsetti A, Solère M. Negative correlation between plasma fibrinogen and insulin sensitivity measured with the minimal model technique. Clin Hemorheol Microcirc. 1998; 18(4): 323-30.
32. Raynaud E, Brun JF, Perez-Martin A, Mercier J. Association between fibrinogen levels and insulin resistance. Diabetes Care. 1998; 21(11): 2040-1.
33. Raynaud E, Pérez-Martin A, Brun JF, Aissa Benhaddad A, Fédou C, Mercier J. Relationships between fibrinogen and insulin resistance. Atherosclerosis 2000; 150 (2): 365-370.
34. Dumortier M, Brandou F, Perez-Martin A, Fedou C, Mercier J, Brun JF. Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes Metab. 2003; 29(5):509-18.
35. Manetta J, Brun JF, Maimoun L, Callis A, Préfaut C, Mercier J. Effect of training on the GH/IGF-I axis during exercise in middle-aged men: relationship to glucose homeostasis. Am J Physiol Endocrinol Metab. 2002; 283(5):E929-36.
36. Brun JF, Khaled S, Raynaud E, Bouix D, Micallef JP, Orsetti A. The triphasic effects of exercise on blood rheology: which relevance to physiology and pathophysiology? Clin Hemorheol Microcirc. 1998; 19: 89-104.
37. Brun JF. Exercise hemorheology as a three acts play with metabolic actors: is it of clinical relevance? Clin Hemorheol Microcirc. 2002;26(3):155-74.
38. Brun JF, Bouchahda C, Chaze D, Benhaddad AA, Micallef JP, Mercier J. The paradox of hematocrit in exercise physiology: which is the "normal" range from an hemorheologist's viewpoint? Clin Hemorheol Microcirc. 2000; 22(4):287-303.
39. Dumortier M, Pérez-Martin A, Pierrisnard E, Mercier J, Brun JF. Regular exercise (3x45 min/wk) decreases plasma viscosity in sedentary obese, insulin resistant patients parallel to an improvement in fitness and a shift in substrate oxidation balance. Clin Hemorheol Microcirc. 2002;26(4):219-29.
40. Aloulou I, Varlet-Marie E, Mercier J, Brun JF. Hemorheologic effects of low intensity endurance training in sedentary patients suffering from the metabolic syndrome. Clin Hemorheol Microcirc. 2006; 35(1-2):333-9.
41. Brooks GA, Mercier J. Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. J Appl Physiol. 1994; 76(6): 2253-61.
42. Brun JF, Jean E, Ghanassia E, Flavier S, Mercier J. Metabolic training: new paradigms of exercise training for metabolic diseases with exercise calorimetry targeting individuals. Ann Readapt Med Phys. 2007; 50(6): 528-34.
43. Brun JF, Varlet-Marie E, Cassan D, Manetta J, Mercier J. Blood fluidity is related to the ability to oxidize lipids at exercise. Clin Hemorheol Microcirc. 2004; 30(3-4): 339-43.
44. Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE. Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity. Metabolism. 2007; 56(11): 1470-7.
45. Baron AD. Hemodynamic actions of insulin. Am J Physiol. 1994; 267(2 Pt 1): E187-202.